NR-566 ADVANCED PHARMACOLOGY FOR
CARE OF THE FAMILY MIDTERM WEEK 1
LATEST 2025-2026 EXAM UPDATE QUESTIONS
AND ANSWERS
How to discontinue phetermine and/or topiramate - Answer-Gradually,
withdrawal sx including seizure may occur with abrupt discontinuation
Lorcaserin baseline data needed: - Answer-Rule out
Pulmonary HTN
Valvular disease
Lorcaserin On going assessment - Answer-Cognitive changes
CBC with diff (Blood dyscrasias)
Phetermine Baseline data needed - Answer-Cardiac assessment
Ongoing Monitoring/assessment for Phetermine - Answer-Cardiac
assessment
Lorcaserin patient education: - Answer-Increased r/o hypoglycemia in
DM
,Do not take in pregnancy
Do not increase insulin doses
Orlistat Patient Education - Answer-Stools may be oily
Fecal incontinence may occur
Take a Vitamin with A,D,E & K (fat soluble)
Levothyroxine/Orlistat taken 4 hours apart
Warfarin should be decreased
Take with food
Fat should be 30% of oral intake
BMI level that bariatric surgery should be considered - Answer->35
Obesity Stage 0 - Answer-BMI 25 or > with no complications
Treat with lifestyle modifications
If not successful add drugs
Obesity Stage 1 - Answer-BMI 25 or > with 1 or more mild/moderate
complication
Treat with lifestyle modifications
Drugs if unsuccessful or BMI 27 or >
Obesity Stage 2 - Answer-BMI 25 or > with 1 complication requiring
significant weight loss
, Consider drugs for BMI 25-26
Prescribe drugs for BMI 27 or >
Schedule IV weight loss drugs - Answer-Lorcaserin
Diethylproprion
Phentermine/toprimate
DM Type II, Gallbladder disease, Gout, Fatty liver are complications of
- Answer-BMI between 30-40
Metroniadazole Patient teaching - Answer-Avoid alcohol
May cause a metallic taste
Avoid in 1st trimester of pregnancy
Monitoring needs for long-term antifungal use - Answer-Liver function
&
Alkaline phosphate
Which anthelmintic drugs is safe to prescribe without obtaining baseline
data - Answer-Pyrantel Pamoate
Which anthelmintic drug causes bone marrow suppression and liver
impairment - Answer-Albendazole and Mebendazole
CARE OF THE FAMILY MIDTERM WEEK 1
LATEST 2025-2026 EXAM UPDATE QUESTIONS
AND ANSWERS
How to discontinue phetermine and/or topiramate - Answer-Gradually,
withdrawal sx including seizure may occur with abrupt discontinuation
Lorcaserin baseline data needed: - Answer-Rule out
Pulmonary HTN
Valvular disease
Lorcaserin On going assessment - Answer-Cognitive changes
CBC with diff (Blood dyscrasias)
Phetermine Baseline data needed - Answer-Cardiac assessment
Ongoing Monitoring/assessment for Phetermine - Answer-Cardiac
assessment
Lorcaserin patient education: - Answer-Increased r/o hypoglycemia in
DM
,Do not take in pregnancy
Do not increase insulin doses
Orlistat Patient Education - Answer-Stools may be oily
Fecal incontinence may occur
Take a Vitamin with A,D,E & K (fat soluble)
Levothyroxine/Orlistat taken 4 hours apart
Warfarin should be decreased
Take with food
Fat should be 30% of oral intake
BMI level that bariatric surgery should be considered - Answer->35
Obesity Stage 0 - Answer-BMI 25 or > with no complications
Treat with lifestyle modifications
If not successful add drugs
Obesity Stage 1 - Answer-BMI 25 or > with 1 or more mild/moderate
complication
Treat with lifestyle modifications
Drugs if unsuccessful or BMI 27 or >
Obesity Stage 2 - Answer-BMI 25 or > with 1 complication requiring
significant weight loss
, Consider drugs for BMI 25-26
Prescribe drugs for BMI 27 or >
Schedule IV weight loss drugs - Answer-Lorcaserin
Diethylproprion
Phentermine/toprimate
DM Type II, Gallbladder disease, Gout, Fatty liver are complications of
- Answer-BMI between 30-40
Metroniadazole Patient teaching - Answer-Avoid alcohol
May cause a metallic taste
Avoid in 1st trimester of pregnancy
Monitoring needs for long-term antifungal use - Answer-Liver function
&
Alkaline phosphate
Which anthelmintic drugs is safe to prescribe without obtaining baseline
data - Answer-Pyrantel Pamoate
Which anthelmintic drug causes bone marrow suppression and liver
impairment - Answer-Albendazole and Mebendazole
